Drug profile · INN
isoflurophate
FLOROPRYL
isoflurophate (FLOROPRYL) is a acetylcholinesterase inhibitor. Route of administration: ophthalmic. Current US regulatory status: approved.
Drug details — isoflurophate
- US status
- approved
- Class
- —
- Route
- OPHTHALMIC
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
isoflurophate (FLOROPRYL) is a acetylcholinesterase inhibitor. Route of administration: ophthalmic. Current US regulatory status: approved.
Key facts
Mechanism of action
Acetylcholinesterase inhibitor
Primary target: Acetylcholinesterase
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is isoflurophate?
isoflurophate (FLOROPRYL) is a acetylcholinesterase inhibitor. Route of administration: ophthalmic. Current US regulatory status: approved.
What is the brand name for isoflurophate?
FLOROPRYL is a marketed brand name for isoflurophate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of isoflurophate?
isoflurophate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.